National to roll back free prescription fees to pay for 13 cancer treatments

21 August 2023 - The National Party wants to bring back the $5 prescription fee for those who can afford ...

Read more →

PHARMAC proposes widening access to a brain cancer treatment to help reduce the impact of a discontinuation

11 August 2023 - PHARMAC is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type ...

Read more →

PHARMAC considers access criteria for COVID-19 anti-viral treatments

1 August 2023 - PHARMAC is consulting on changes to the access criteria for all COVID-19 anti-viral treatments to include ...

Read more →

New Zealand Pharmaceutical Schedule - 1 August 2023

1 August 2023 - The August 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Shingles can be deadly, so why is the vaccine only free for one year of life?

25 July 2023 - One in three people are at risk of developing shingles in their lifetime and the risk increases ...

Read more →

New Zealand Pharmaceutical Schedule - 1 July 2023

1 July 2023 - The July 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

PHARMAC confirms funding of rituximab for IgG4 related disease

7 June 2023 - PHARMAC has published a notification for widened access to rituximab (Riximyo) for people with the chronic inflammatory ...

Read more →

Mid-life women being let down by PHARMAC, say menopause experts

6 June 2023 - New Zealand women in mid-life are being let down by Pharmac, say two doctors specialising in ...

Read more →

New Zealand Pharmaceutical Schedule - 1 June 2023

1 June 2023 - The June 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Ovarian cancer: Bay of Plenty mother spends more than $130,000 on treatments

12 May 2023 - Four cancer treatments in three years: $132,775. ...

Read more →

Time taken for PHARMAC funding decisions ‘too long’, says Medicines NZ

26 April 2023 - It takes the nation's drug-buying agency, PHARMAC, an average of 7.7 years to make funding decisions ...

Read more →

PHARMAC funds second treatment for spinal muscular atrophy

11 April 2023 - PHARMAC has announced the funding of risdiplam (Evrysdi) for people with the rare genetic disorder spinal muscular ...

Read more →

PHARMAC shares next steps in reviewing rule 8.1b

5 April 2023 - PHARMAC’s consultation on rule 8.1b of the Pharmaceutical Schedule has now closed. ...

Read more →

PHARMAC seeking feedback on the COVID-19 anti-viral molnupiravir

4 April 2023 - PHARMAC are consulting on the role of molnupiravir in New Zealand’s portfolio of COVID-19 treatments.  ...

Read more →

New Zealand Pharmaceutical Schedule - 1 April 2023

1 April 2023  The April 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →